India’s Bharat Biotech applies to hold COVAXIN clinical trials in Bangladesh

India’s Bharat Biotech has sought approval from the authorities to hold clinical trials of its coronavirus vaccine candidate COVAXIN in Bangladesh

Jan 23, 2021
Image
A

India’s Bharat Biotech has sought approval from the authorities to hold clinical trials of its coronavirus vaccine candidate COVAXIN in Bangladesh.

The company applied for the approval around two weeks ago, said Dr Syed Modasser Ali, the chairman of Bangladesh Medical Research Council.

The application for the phase three trial has been sent to the council’s Ethical Review Committee for scrutiny, he said on Friday.

downloadingmymind.com

SPS-NBN

News Behind the News Special Studies

Tweets about SAMonitor
SAM Facebook

Newsletter Subscription

The subscriber's email address.
Stay informed - subscribe to our newsletter.